A position-signal processing method for flat panel gamma imaging probe includes a modeling phase and a use phase. In the modeling phase, a weight direction for an imaging detector is defined, position centers and weight ratios of the imaging detector in the weight direction are utilized to obtain a distribution graph of the weight ratios to the position centers, and curve fitting is performed upon the distribution graph to obtain a position estimation curve. In the use phase, the position estimation curve is utilized to derive a position estimation value of a probe trigger event in a 2D crystal diagram, a position value of the probe in the 2D crystal diagram with respect to the position estimation value of the probe trigger event is obtained, and a crystal code is located in a crystal code look-up table for the position value of the probe in the 2D crystal diagram.

Devices, systems, and methods for localized delivery of a chemotherapy, hormonal therapy, or targeted drug/biologic therapy to a target tissue area of an internal body organ of a patient. Computer systems may be used for planning and navigation in super selective drug delivery via a tracheobronchial airway. A catheter may be used to form a sealed treatment chamber in a natural lumen extending through the target tissue area. Air is purged from the chamber, which is then filled with a liquid drug solution for an adequate treatment session time, solution volume and drug concentration to saturate the target tissue area, thereby providing the treatment. The liquid drug solution may be circulated or recirculated through the chamber or maintained stationary therewithin to saturate the target tissue area. The chamber is evacuated at the end of the treatment session.

A method for determining an abnormality in a medical device from a medical image is provided. The method for determining an abnormality in a medical device comprises receiving a medical image, and detecting information on at least a part of a target medical device included in the received medical image.

Systems and methods of PET attenuation correction using low-field MR image data includes receiving a first set of image data and a set of low-field magnetic resonance (MR) image data. An attenuation correction map is generated from the low-field MR image data using a first trained neural network. At least one attenuation correction process is applied to the first set of image data based on the attenuation correction map to generate at least one clinical attenuation-corrected image.

A system and method for patient positioning during radiotherapy. The system can include a patient support structure configured to receive a patient during a radiotherapy process using a radiotherapy source to deliver a therapy to the patient when positioned on the patient support structure, a patient positioning system configured to adjust a position of the patient support structure relative to the radiotherapy source, a flexible actuator configured to secure the patient to the patient support and adjust a position of the patient relative to the patient support, and an imaging system configured to acquire imaging data of the patient, the patient support, and the flexible actuator during the radiotherapy process.

The disclosure is directed to a device that includes a cavity formed by a plurality of rails, the plurality of rails connected to both a first support and a second support, each at predetermined intervals about a circumference of the first support and the second support; and at least one particle detection device operably connected to each rail of the plurality of rails. The disclosure is also directed to a scanner that includes the device, and a processor.

A method for adaptive coincidence data processing is provided. The method includes detecting positron annihilation events with a detector array of a positron emission tomography (PET) scanner, wherein the PET scanner includes multiple detector rings disposed along a longitudinal axis of the PET scanner, and each detector ring includes multiple detectors. The method also includes, within a given time period, dynamically adjusting a number of positron annihilation events accepted and transmitted to acquisition circuitry for processing utilizing a numerical difference in detector rings along the longitudinal axis between a first detector and a second detector detecting respective annihilation photons from a positron annihilation event.

A method for forming a virtual 3D mathematical model of a dental system, including receiving DICOM files representing the dental system; identifying number and location of voxels of tissues of the dental system; combining the voxels of the tissues into voxels of organs of the dental system; combining the organs into the virtual 3D mathematical model of the dental system, wherein the virtual 3D mathematical models supports linear, non-linear and volumetric measurements of the dental system; and presenting the virtual 3D mathematical model to a user. The DICOM files can be cone beam or multispiral computed tomography, MRT, PET and/or ultrasonography. The tissues include enamel, dentin, pulp, cartilage, periodontium, and/or jaw bone. The organs include teeth, gums, temporomandibular joint and/or jaw. A size of the voxels is typically between 40 μm and 200 μm.

A method for adaptive coincidence data processing is provided. The method includes detecting positron annihilation events with a detector array of a positron emission tomography (PET) scanner, wherein the PET scanner includes multiple detector rings disposed along a longitudinal axis of the PET scanner, and each detector ring includes multiple detectors. The method also includes, within a given time period, dynamically adjusting a number of positron annihilation events accepted and transmitted to acquisition circuitry for processing utilizing a numerical difference in detector rings along the longitudinal axis between a first detector and a second detector detecting respective annihilation photons from a positron annihilation event.

Systems and methods for destroying or inhibiting cancer cells and other rapidly-dividing cells include coupling an alternating polarity (AP) magnetic field generator to a target body area and applying an AP magnetic field having a frequency of 0.5-500 kHz and a field strength of 0.5-5 mT to the target body area to achieve a desired inhibiting effect on cancer cells or other rapidly-dividing cells. Treatments provided by the system may be co-administered with an anti-cancer drug such as a chemotherapy drug, a hormone therapy drug, targeted therapy drugs, immunotherapy drugs, or an angiogenesis inhibitor drug.